🔊CEOInterviews

Jacob Leach on product launch

From A new era of CGM? Dexcom’s Jake Leach on Stelo, G7 updates and more. · · DiabetesConnections

“We're incredibly excited about Stell — it is the first over‑the‑counter CGM product approved and launched in the United States; it's built on the G7 hardware but delivers a completely different user experience tailored for adults who don't take insulin.”

Jacob Leach
Interim Chief Executive Officer, President & Chief Operating Officer, DexCom Inc
product launchaccessCGM

On , Jacob Leach, Interim Chief Executive Officer, President & Chief Operating Officer at DexCom Inc, spoke about product launch during A new era of CGM? Dexcom’s Jake Leach on Stelo, G7 updates and more. on DiabetesConnections.

A new era of CGM? Dexcom’s Jake Leach on Stelo, G7 updates and more.
Watch on YouTube at 6:56
A new era of CGM? Dexcom’s Jake Leach on Stelo, G7 updates and more.
DiabetesConnections
Watch on YouTube at 6:56
For the first time, you can buy a continuous glucose monitor over the counter, no prescription needed. This summer we went from no CGMs available this way, to now having two. This week we’re talking about the Dexcom Stelo with the company’s COO Jake Leach. We’ll talk about Stelo and get an update on G7 features including Dexcom’s plans to address concerns over Geofencing, and issues that can potentially arise if you travel outside your home country. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.
Jacob Leach

About Jacob Leach

Interim Chief Executive Officer, President & Chief Operating Officer · DexCom Inc

Jacob Leach, who became interim CEO of Dexcom in early 2026 after previously serving as president and COO, has been leading the company through a period of public engagement with users following reported issues with the Dexcom G7 sensor. In several interviews in June 2026, Leach discussed the formation of a Customer Advisory Council, which he said was created to provide a more direct feedback mechanism from users, caregivers, and healthcare professionals. He stated that a key takeaway from the council was that the company needed to improve communication with the community about product changes and fixes. Leach also described improvements to the G7, including a new Bluetooth antenna and adhesive enhancements, and said that accuracy complaint rates were at an "all-time low." Leach has discussed the upcoming Dexcom G8 sensor, describing it as a new platform with a "self-calibrating" technology that uses an additional signal to adapt to the user's physiology without requiring fingerstick calibration. He stated that the G8 will be half the size of the G7 and will add multi-analyte capabilities, including the ability to monitor potassium, which he noted is a dangerous condition for which there is no at-home test. On earnings calls, Leach reported that Dexcom acquired the nutritional coaching company Nutrisense and that the company's goal is to have the first continuous glucose monitor approved for use in the inpatient hospital setting. He also stated that the company is focused on improving customer service and that the customer is the "northstar" for the company.

Profile compiled from Jacob Leach's verified public interviews and appearances. See all quotes & transcripts →

This quote was transcribed and extracted with AI assistance from a verified, first-person interview, then reviewed by our team to confirm the speaker and the exact wording. See how we verify →

More from Jacob Leach Dexcom (DXCM) Full Transcript Explore All Executives